{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:47:11Z","timestamp":1789667231572,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["304716\/2014-6"],"award-info":[{"award-number":["304716\/2014-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","award":["E-26\/201.497\/2014"],"award-info":[{"award-number":["E-26\/201.497\/2014"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejmech.2017.08.034","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T01:30:41Z","timestamp":1502933441000},"page":"698-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["1-Aryl-1 H - and 2-aryl-2 H -1,2,3-triazole derivatives blockade P2X7 receptor in\u00a0vitro and inflammatory response in\u00a0vivo"],"prefix":"10.1016","volume":"139","author":[{"given":"Daniel Tadeu Gomes","family":"Gonzaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Braga Gomes","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thadeu Estevam","family":"Moreira Maramaldo Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Lidmar","family":"von Ranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Anast\u00e1cio Furtado Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Sposito Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Carvalho","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Pereira","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9rcules Rezende","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Augusto","family":"de Melo Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Penido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo Lamim","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Carla","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Francisco","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Xavier","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando de Carvalho","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.08.034_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2017.08.034_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11302-013-9357-4","article-title":"Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses","author":"Jacob","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.ejmech.2017.08.034_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5414\/CN107325","article-title":"P2 purinoceptors: renal pathophysiology and therapeutic potential","volume":"78","author":"Booth","year":"2012","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signalling and cancer","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.ejmech.2017.08.034_bib5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2174\/156802609789869619","article-title":"Inflammation as a therapeutic target in acute ischemic stroke treatment","volume":"9","author":"Tuttolomondo","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.108.141853","article-title":"Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation","volume":"327","author":"Broom","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.08.034_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A\u00a0potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2017.08.034_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1165\/rcmb.2010-0129OC","article-title":"A\u00a0potential role for P2X7R in allergic airway inflammation in mice and humans","volume":"44","author":"M\u00fcller","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.prostaglandins.2012.09.005","article-title":"Activation of calcium-insensitive phospholipase A(2) (iPLA(2)) by P2X(7) receptors in murine peritoneal macrophages","volume":"99","author":"El Ouaaliti","year":"2012","journal-title":"Prostagl. Other Lipid Mediat"},{"key":"10.1016\/j.ejmech.2017.08.034_bib10","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.1002780","article-title":"The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF","volume":"187","author":"Lemaire","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/boc.201200088","article-title":"MED1101: a new dialdehydic compound regulating P2X7 receptor cell surface expression in U937 cells","volume":"105","author":"Muzzachi","year":"2013","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ejmech.2017.08.034_bib12","doi-asserted-by":"crossref","first-page":"C1793","DOI":"10.1152\/ajpcell.1997.273.6.C1793","article-title":"P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells","volume":"273","author":"Coutinho-Silva","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.bjp.0701447","article-title":"ATP, a partial agonist for the P2Z receptor of human lymphocytes","volume":"122","author":"Gargett","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11302-012-9319-2","article-title":"P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line","volume":"8","author":"Gehring","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.ejmech.2017.08.034_bib15","doi-asserted-by":"crossref","first-page":"C568","DOI":"10.1152\/ajpcell.00380.2004","article-title":"Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels","volume":"288","author":"Sugiyama","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib16","doi-asserted-by":"crossref","first-page":"28142","DOI":"10.1074\/jbc.M501290200","article-title":"A\u00a0role for mitogen-activated protein kinase (Erk1\/2) activation and non-selective pore formationin P2X7 receptor-mediated thymocyte death","volume":"280","author":"Auger","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/cmi.12001","article-title":"P2X7 receptor regulation of non-classical secretion from immune effector cells","volume":"14","author":"Dubyak","year":"2012","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1096\/fj.12-205765","article-title":"P2X7 receptor-stimulation causes fever via PGE2 and IL-1\u03b2 release","volume":"26","author":"Barber\u00e0-Cremades","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2017.08.034_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jnc.12143","article-title":"The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail","volume":"124","author":"Cervetto","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib20","first-page":"132","article-title":"Intra-articular blockade of P2X7 receptor reduces the articular hyperalgesia and inflammation in the knee joint synovitis especially in female rats","volume":"18","author":"Teixeira","year":"2017","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2017.08.034_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1242\/dmm.017038","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ejmech.2017.08.034_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12974-016-0621-8","article-title":"Interleukin-1\u03b2 has trophic effects in microglia and its release is mediated by P2X7R pore","volume":"13","author":"Monif","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2017.08.034_bib23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2017.08.034_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2005.01.002","article-title":"Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain","volume":"114","author":"Chessell","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2017.08.034_bib25","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1000436","article-title":"P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases","volume":"185","author":"Lopez-Castejon","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib26","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1476-5381.2009.00135.x","article-title":"Mechanism of action of species-selective P2X(7) receptor antagonists","volume":"156","author":"Michel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib28","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1124\/jpet.106.111559","article-title":"A-740003 [N-(1-[(cyanoimino) (5-quinolinylamino) methyl]amino-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl) acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat","volume":"319","author":"Honore","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2017.08.034_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/ml400040v","article-title":"Synthesis and pharmacological characterization of two novel, brain penetrating P2X7 antagonists","volume":"4","author":"Letavic","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib30","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/jm051202e","article-title":"Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists","volume":"49","author":"Nelson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2009.05.018","article-title":"The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice","volume":"204","author":"Honore","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2017.08.034_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bjp.0707265","article-title":"Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states","volume":"151","author":"Donnelly-Roberts","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2017.08.034_bib34","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2125.2012.04200.x","article-title":"Effects of genetic variation in the P2RX7 gene on pharmacodynamics of a P2X(7) receptor antagonist: a prospective genotyping approach","volume":"74","author":"McHugh","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib36","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.3390\/molecules171113009","article-title":"Action of natural products on p2 receptors: a reinvented era for drug discovery","volume":"17","author":"Faria","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.08.034_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/13543776.2013.749862","article-title":"Novel 1H-1,2,3-, 2H-1,2,3-, 1H-1,2,4- and 4H-1,2,4-triazole derivatives: a patent review (2008-2011)","volume":"23","author":"Ferreira","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2017.08.034_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2008.02.047","article-title":"Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates","volume":"44","author":"da Silva","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib41","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7164\/antibiotics.47.1030","article-title":"Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones","volume":"47","author":"Im","year":"1994","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2017.08.034_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-1211(00)00185-6","article-title":"Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy","volume":"43","author":"Palhagen","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejmech.2017.08.034_bib43","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0968-0896(03)00055-5","article-title":"Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives","volume":"11","author":"Cunha","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib44","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmc.2009.03.053","article-title":"Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides","volume":"17","author":"Jord\u00e3o","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib45","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/S0968-0896(03)00487-5","article-title":"Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands","volume":"11","author":"Menegatti","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib46","first-page":"1181","article-title":"Studies on 1,2,3-triazole derivatives as in\u00a0vitro inhibitors of prostaglandin synthesis","volume":"45","author":"Biagi","year":"1990","journal-title":"Farmaco"},{"key":"10.1016\/j.ejmech.2017.08.034_bib47","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/jm2003624","article-title":"Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (atccATCC 27294) strain","volume":"54","author":"Boechat","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib48","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1016\/j.bmc.2011.07.035","article-title":"Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides","volume":"19","author":"Jord\u00e3o","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07328303.2010.511749","article-title":"Synthesis and antitubercular evaluation of new bis-1,2,3-triazoles derived from d-mannitol","volume":"29","author":"Ferreira","year":"2010","journal-title":"J.\u00a0Carbohydr. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib50","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2174\/15680266113136660202","article-title":"Recent advances in the synthesis of new antimycobacterial agents based on the 1H-1,2,3-triazoles","volume":"13","author":"Gonzaga","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib51","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bmc.2011.02.007","article-title":"Synthesis and anti-HSV-1 activity of new 1,2,3-triazole derivatives","volume":"19","author":"Jord\u00e3o","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1590\/S0103-50532009000400007","article-title":"Cytotoxic, trypanocidal activities and physicochemical parameters of nor-beta-lapachone-based 1,2,3-triazoles","volume":"20","author":"da Silva J\u00fanior","year":"2009","journal-title":"J.\u00a0Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.08.034_bib53","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ejmech.2007.02.020","article-title":"Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents","volume":"42","author":"Ferreira","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/1573406411309080010","article-title":"Synthesis of 1H-1,2,3-triazoles and study of their antifungal and cytotoxicity activities","volume":"9","author":"da Silva","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib55","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/jm901265h","article-title":"Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2013.12.039","article-title":"1-Phenyl-1H- and 2-phenyl-2H-1,2,3-triazol derivatives: design, synthesis and inhibitory effect on alpha-glycosidases","volume":"74","author":"Gonzaga","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib57","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1016\/j.bmcl.2007.04.075","article-title":"Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7antagonists","volume":"17","author":"Carroll","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11302-008-9110-6","article-title":"Selective P2X7receptor antagonists for chronic inflammation and pain","volume":"5","author":"Carroll","year":"2009","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.ejmech.2017.08.034_bib59","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bmcl.2008.01.095","article-title":"Synthesis and in\u00a0vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists","volume":"18","author":"Florjancic","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib60","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00210-010-0523-8","article-title":"Large-conductance channel formation mediated by P2X7 receptor activation is regulated through distinct intracellular signaling pathways in peritoneal macrophages and 2BH4 cells","volume":"382","author":"Faria","year":"2010","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib62","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in\u00a0vitro drug metabolism data in predicting in\u00a0vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib63","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck Molecular Force Field I. basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J.\u00a0Comp. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib64","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jcc.20425","article-title":"RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br and I","volume":"27","author":"Rocha","year":"2006","journal-title":"J.\u00a0Comp. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejmech.2017.08.034_bib66","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2017.08.034_bib67","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1021\/jp960669l","article-title":"Density functional theory of electronic structure","volume":"100","author":"Kohn","year":"1996","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2017.08.034_bib69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib70","doi-asserted-by":"crossref","first-page":"e22153","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2017.08.034_bib71","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1074\/jbc.M110.167437","article-title":"Amino acid residues constituting the agonist binding site of the human P2X3 receptor","volume":"286","author":"Bodnar","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib72","doi-asserted-by":"crossref","first-page":"34190","DOI":"10.1074\/jbc.M005481200","article-title":"Identification of amino acid residues contributing to the ATP-binding site of a purinergic P2X receptor","volume":"275","author":"Jiang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2013.12.039","article-title":"1-Phenyl-1H- and 2-phenyl-2H-1,2,3-triazol derivatives: design, synthesis and inhibitory effect on alpha-glycosidases","volume":"74","author":"Gonzaga","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib74","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A\u00a0stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ligation of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2017.08.034_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00424-006-0070-9","article-title":"Pharmacology of P2X channels","volume":"452","author":"Gever","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ejmech.2017.08.034_bib76","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2017.08.034_bib77","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.bmcl.2011.04.024","article-title":"Synthesis and in\u00a0vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X7 antagonists","volume":"21","author":"Perez-Medrano","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib78","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2017.08.034_bib79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02265122","article-title":"Acute paw oedema formation induced by ATP: re-evaluation of the mechanisms involved","volume":"45","author":"Ziganshina","year":"1996","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2017.08.034_bib80","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0705650","article-title":"Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression","volume":"142","author":"Posadas","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib81","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","article-title":"Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373","volume":"149","author":"Stokes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib82","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2016.07.020","article-title":"Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists","volume":"116","author":"Caseley","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib84","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bmcl.2017.01.039","article-title":"Escape from adamantane: scaffold optimization of novel P2X7 antagonists featuring complex polycycles","volume":"27","author":"Barniol-Xicota","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib85","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2017.08.034_bib86","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.bmcl.2010.03.094","article-title":"Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist","volume":"20","author":"Chen","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib87","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.bmcl.2015.06.004","article-title":"Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists","volume":"25","author":"Rudolph","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib88","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00089","article-title":"Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists","volume":"24","author":"Savall","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib89","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1016\/j.bmcl.2010.07.033","article-title":"Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor","volume":"20","author":"Abdi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.08.034_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2009.11.011","article-title":"Peripheral origin of IL-1bproduction in the rodent hippocampus under in\u00a0vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors","volume":"219","author":"Cs\u00f6lle","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.ejmech.2017.08.034_bib91","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1096\/fj.12-205765","article-title":"P2X7 receptor-stimulation causes fever via PGE2 and IL-1brelease","volume":"26","author":"Barber\u00e0-Cremades","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2017.08.034_bib92","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0028-3908(97)00141-X","article-title":"Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor","volume":"36","author":"Virginio","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2017.08.034_bib93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/wmts.1","article-title":"Pharmacology of P2X receptors","volume":"1","author":"Syed","year":"2012","journal-title":"WIREs Membr. Transp. Signal"},{"key":"10.1016\/j.ejmech.2017.08.034_bib94","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/acschemneuro.5b00303","article-title":"Novel phenyl-substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain","volume":"7","author":"Chrovian","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.08.034_bib95","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1021\/acs.jmedchem.5b00365","article-title":"Novel series of dihydropyridinone P2X7 receptor antagonists","volume":"58","author":"Lopez-Tapia","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.08.034_bib96","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1523\/JNEUROSCI.3295-09.2010","article-title":"P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide","volume":"30","author":"Clark","year":"2010","journal-title":"J.\u00a0Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417306372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:31:11Z","timestamp":1719394271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417306372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":96,"alternative-id":["S0223523417306372"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in\u00a0vitro and inflammatory response in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}